© 2022 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Health

MSU's Bachmann develops new uses for existing drugs to treat childhood cancer

bachmannPicture.jpg
msutoday
/
Dr. André Bachmann"

André Bachmann and his associates at the Secchia Center in Grand Rapids have been hard at work developing a new drug for cancer patients. It has the potential to be effective in treating neuroblastoma—a common form of childhood cancer.

 

The American Cancer Society lists neuroblastoma as the most prevalent cancer in infants. Bachmann’s research involves repurposing the drugs DFMO and TIR-199 to treat the deadly strain.

WKAR's Skyler Ashley spoke with Dr. Bachmann to gain insight into his research and learn more about the process of what it takes to get a drug on the market to treat cancer patients.

Related Content
News from WKAR will never be behind a paywall. Ever. We need your help to keep our coverage free for everyone. Please consider supporting the news you rely on with a donation today. You can support our journalism for as little as $5. Every contribution, no matter the size, propels our vital coverage. Thank you.